Evaluation of Depression, Anxiety, and Sexual Function in Rectal Cancer Patients Before and After Neoadjuvant Chemoradiotherapy
Authors:
- 7 June 2023
- journal article
- research article
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 54 (4) , 1347-1352
Abstract
Objective The association of treatment-related side effects and tumor characteristics with sexual function, depression, and anxiety were investigated in patients with locally advanced rectum cancer (LARC) receiving neoadjuvant chemoradiotherapy (CRT). Material and Methods Thirty-two patients who received neoadjuvant CRT with LARC were included. The Arizona Sexual Experiences (ASEX) Scale was used to determine the sexual function status whereas the Beck Depression Inventory (BDI) and the Beck Anxiety Inventory (BAI) were used to evaluate the depression and anxiety status of the patient, respectively. The patients were asked to fill these scales before and at least 4 weeks after the neoadjuvant CRT. T-test and Mann–Whitney U test were used for the comparison of values. Results Median age was 52.5 years (range: 33–76). Twenty-six patients were male, and 6 patients were female. At presentation, the tumor was located mostly in lower third rectum (72%), and 69% of the patients had T3 tumors. There was a statistically significant deterioration in the sexual functions of the patients (p < 0.001), a statistically significant decrease in their anxiety level after CRT (p: 0.037). Depression level was changed from mild to minimal during this process (p: 0.17). A significant deterioration in the ASEX scale was observed especially in patients with grade 2 and above gastrointestinal side effects (p: 0.01). Conclusion This prospective study showed that the patient’s anxiety and depression levels had decreased during the treatment process probably due to the decrease in the patient’s symptoms. However, deterioration of the sexual function status which might be correlated to increased gastrointestinal side effects during CRT has been observed. So, clinical and psychiatric support including therapies for sexual dysfunctions is needed for LARC patients during and after the neoadjuvant CRT.Keywords
This publication has 31 references indexed in Scilit:
- Literature review: preoperative radiotherapy and rectal cancer – impact on acute symptom presentation and quality of lifeJournal of Clinical Nursing, 2013
- The Quality-of-Life Effects of Neoadjuvant Chemoradiation in Locally Advanced Rectal CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- Urinary and sexual dysfunction after rectal cancer treatmentNature Reviews Urology, 2010
- Sexual dysfunction following surgery for rectal cancer - a clinical and neurophysiological studyJournal of Experimental & Clinical Cancer Research, 2009
- Health-related quality of life, faecal continence and bowel function in rectal cancer patients after chemoradiotherapy followed by radical surgerySupportive Care in Cancer, 2009
- Elective Clinical Target Volumes for Conformal Therapy in Anorectal Cancer: A Radiation Therapy Oncology Group Consensus Panel Contouring AtlasInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Risk factors for sexual dysfunction after rectal cancer treatmentEuropean Journal of Cancer, 2009
- Anxiety and depression in patients with gastrointestinal cancer: does knowledge of cancer diagnosis matter?BMC Gastroenterology, 2007
- Are anxiety and depressed mood related to physical symptom burden? A study in hospitalized advanced cancer patientsPalliative Medicine, 2007
- The relationship of psychological distress, extent of disease, and performance status in patients with lung cancerCancer, 1987